These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39069389)

  • 21. Real-World Effectiveness of Preventive Pharmacological Therapy in Patients With Urolithiasis: A Retrospective Cohort Study.
    Hollingsworth JM; Oerline MK; Hsi RS; Crivelli JJ; Krampe N; Asplin JR; Shahinian VB
    Am J Kidney Dis; 2024 Jul; 84(1):83-93.e1. PubMed ID: 38432593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Urolithiasis in Patients Following Lower Urinary Tract Reconstruction with Intestinal Segments.
    Marien T; Robles J; Kammann TM; Kadihasanoglu M; Viprakasit DP; Herrell SD; Miller NL
    J Endourol; 2017 Mar; 31(3):217-222. PubMed ID: 27936931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Follow-up after urolithiasis management].
    Stritt K; Bosshard P; Roth B
    Urologe A; 2022 May; 61(5):500-507. PubMed ID: 35381865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed stones: urinary stone composition, frequency and distribution by gender and age.
    Siener R; Rüdy J; Herwig H; Schmitz MT; Schaefer RM; Lossin P; Hesse A
    Urolithiasis; 2024 Jan; 52(1):24. PubMed ID: 38189998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation and treatment of pediatric idiopathic urolithiasis-revisited.
    Alon US; Zimmerman H; Alon M
    Pediatr Nephrol; 2004 May; 19(5):516-20. PubMed ID: 15015063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dual-energy computed tomography in the diagnostics of urolithiasis].
    Kapanadze LB; Rudenko VI; Serova NS; Rapoport LM; Aleksandrova KA; Novikov AA
    Urologiia; 2019 Dec; (5):31-36. PubMed ID: 31808629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis.
    Türk C; Petřík A; Sarica K; Seitz C; Skolarikos A; Straub M; Knoll T
    Eur Urol; 2016 Mar; 69(3):468-74. PubMed ID: 26318710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inluence of osteoporosis and its causative factors on the prevention of recurrence of urinary stone disease].
    Demidko LS; Rudenko VI; Fadeev VV; Demidko YL; Amosov AV; Kuzmicheva GM; Grigoryan VA; Enikeev ME; Amosova MV
    Urologiia; 2019 Sep; (4):26-31. PubMed ID: 31535801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LITHOSCREEN: a comprehensive screening program and database for the assessment and treatment management of patients with kidney stones.
    Robertson WG
    Urolithiasis; 2021 Oct; 49(5):387-397. PubMed ID: 34086105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of urolithiasis using febuxostat in patients with metabolic syndrome].
    Protoshchak VV; Paronnikov MV; Babkin PA; Sleptsov AV
    Urologiia; 2023 Jul; (3):13-20. PubMed ID: 37417406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluid intake recommendations in urolithiasis and general advice to patients without metabolic risk factors.
    Kiremit MC; Boyuk A; Petkova K
    World J Urol; 2023 May; 41(5):1251-1259. PubMed ID: 36692534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric urolithiasis--evaluation of risk factors in 95 children.
    Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
    Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Established and recent developments in the pharmacological management of urolithiasis: an overview of the current treatment armamentarium.
    Abou Chakra M; Dellis AE; Papatsoris AG; Moussa M
    Expert Opin Pharmacother; 2020 Jan; 21(1):85-96. PubMed ID: 31714803
    [No Abstract]   [Full Text] [Related]  

  • 35. Follow-up of urolithiasis patients after treatment: an algorithm from the EAU Urolithiasis Panel.
    Lombardo R; Tzelves L; Geraghty R; Davis NF; Neisius A; Petřík A; Gambaro G; Türk C; Somani B; Thomas K; Skolarikos A
    World J Urol; 2024 Mar; 42(1):202. PubMed ID: 38546854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of current guidelines on medical management of stone disease.
    Tzelves L; Mourmouris P; Skolarikos A
    Arch Esp Urol; 2021 Jan; 74(1):171-182. PubMed ID: 33459633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urolithiasis-Therapy and recurrence prevention taking into account gender-specific aspects].
    Siener R; Strohmaier WL; Neisius A
    Urologie; 2022 Oct; 61(10):1076-1082. PubMed ID: 36018380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical treatment of renal stones.
    López Martínez JM; Sierra Del Rio A; Luque Galvez MP
    Arch Esp Urol; 2021 Jan; 74(1):63-70. PubMed ID: 33459622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO; Wipplinger J
    Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.